For viewing our virtual streaming of the 2021 ISDS, please look for your registration confirmation email, which contains the link to the meeting website.
If you cannot find your confirmation email, please get in contact with:
Annette Roman
Icahn School of Medicine at Mount Sinai
Department of Medical Education, Office of Continuing Medical Education
One Gustave L. Levy Place, Box 1193
New York, NY 10029
P 212-731-7950
E annette.roman@mssm.edu
The IEC’s joint symposium with the National Alopecia Areata Foundation (NAAF) and the National Eczema Association (NEA) on “Alopecia Areata and Atopic Dermatitis” will take place immediately before the 2021 Inflammatory Skin Disease Summit (ISDS) in New York, NY on November 3, 2021.
Wednesday, November 3, 2021 | 8:30 am – 1:00 pm Eastern Standard Time
The New York Academy of Medicine | 1216 Fifth Avenue at East 103rd Street, New York, NY, USA
Click here to find out more.
The entire program will be presented at the New York Academy of Medicine, therefore the time schedule below is Eastern Standard Time (EST).
Click on the button below to download the Final Program:
FINAL PROGRAM
| WEDNESDAY, NOVEMBER 3, 2021 |
| 01.00 pm | Registration opens |
| 01.00 pm – 04.00 pm | Poster Viewing |
| Opening
Chairs Opening Session: |
|
| 04.00 pm – 04.10 pm | Welcome address |
| 04.10 pm – 04.35 pm | Setting the stage – Historic perspectives Georg Stingl (Vienna, Austria) |
| 04.35 pm – 05.00 pm | Setting the stage – The translational revolution in inflammatory skin diseases James G. Krueger (New York, NY, USA) |
| 05.00 pm – 05.30 pm | Keynote lecture: Autoinflammatory diseases Dan Kastner (Bethesda, MD, USA) |
| 05.30 pm – 06.30 pm | Chairs Afternoon Session: Joel Gelfand (Philadelphia, PA, USA) Sonja Ständer (Münster, Germany) Oral presentations from selected abstracts (non-CME) Treatment of sarcoidosis with cutaneous involvement with tofacitinib: results of an open-label clinical trial with mechanistic insight Extensive Lymphocyte Clonal Expansion and Formation of Tertiary Lymphoid Structure in Hidradenitis Suppurativa RPT193, an oral CCR4 inhibitor: Efficacy results from a randomized, placebo-controlled Phase 1b monotherapy trial in patients with moderate-to-severe atopic dermatitis Vitiligo Patients Show Significant Changes in Skin and Blood Immune/Melanocytes Biomarkers with Oral JAK3/TEC Inhibitor Ritlecitinib Efficacy and Safety Results of a Randomized, Double-blind, Vehicle-controlled Phase 2 Study of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis Stratifying Risk for Early Onset Atopic Dermatitis from Birth: An Artificial Intelligence Empowered Clinical Decision Support Tool |
| 06.30 pm – 09.00 pm | Reception & poster viewing |
| THURSDAY, NOVEMBER 4, 2021 |
|
08.15 am – 8.45 am |
Chairs – Morning Session: Brian Brown (New York, NY, USA), Miriam Merad (New York, NY, USA) Developmental programs in inflammatory skin disease |
| 08.45 am – 09.15 am | Resident memory T cells in human health and disease Rachael Clark (Boston, MA, USA) |
| 09.15 am – 09.45 am | Regulatory T cells in Skin Michael Rosenblum (San Francisco, CA, USA) |
| 09.45 am – 10.30 am | Oral presentations from selected abstracts (non-CME)
Single-cell analysis unravels lineage plasticity of innate lymphoid cells in atopic dermatitis Commensal microbiome regulates epidermal barrier function and repair of the skin by signaling through the aryl hydrocarbon receptor Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis from infancy to adulthood |
| 10.30 am – 11.00 am | COFFEE BREAK |
| 11.00 am – 12.30 pm | Sponsored Lunch Symposium (Non-CME) supported by Sanofi Genzyme and Regeneron |
| 12.30 pm – 12.45 pm | COFFEE BREAK |
| 12.45 pm – 02.15 pm | Sponsored Lunch Symposium (Non-CME) supported by UCB – Union Chimique Belge |
| 02.15 pm – 02.30 pm | COFFEE BREAK |
| Chairs – Afternoon Session I: Amos Gilhar (Haifa, Israel) Emmilia Hodak (Tel Aviv, Israel)The 2.30pm-6.00pm segment is non-CME. |
|
| 02.30 pm – 03.00 pm | Novel developments in ichthyoses Amy S. Paller (Chicago, IL, USA) |
| 03.00 pm – 03.30 pm | Janus kinases in inflammation John O’Shea (Bethesda, MD, USA) |
| 03.30 pm – 04.00 pm | New therapeutic frontiers in atopic conditions George Yancopoulos (Tarrytown, NY, USA) |
| 04.00 pm – 04.30 pm | COFFEE BREAK |
| 04.30 pm – 05.00 pm | Chairs – Afternoon Session II: Alice Gottlieb (New York, NY, USA) Anne Bowcock (New York, NY, USA) Oral presentations from selected abstracts (non-CME) Deucravacitinib, a Selective TYK2 Inhibitor: Serum Markers of Psoriatic Disease Activity and Pharmacodynamic Responses From a Phase 2 Study Long-Term Efficacy of Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label Extension Trial up to 172 Weeks IL-13 and IL-4 Promote Proliferation and mRNA Expression of MUC2 and MUC5AC in Primary Human Conjunctival Goblet Cells |
| 05.00 pm – 05.30 pm | Visualization of skin inflammation and resulting immunologic concepts Kenji Kabashima (Kyoto, Japan) |
| 05.30 pm – 06.00 pm | Oral presentations from selected abstracts (non-CME)
Spatial transcriptomics of Cutaneous and Systemic Lupus Erythematosus skin reveals insights into cell-cell communications, interferon skewing, and distinguishes clinical subtypes IL-23 maintains tissue resident memory Th17 cells in murine and psoriatic skin Treatment with KHK4083 (AMG 451), an antagonist of OX40, induces durable modulation of atopic dermatitis (AD) related blood/skin biomarkers |
| 06.00 pm – 07.30 pm | Sponsored Dinner Symposium (Non-CME) supported by Boehringer Ingelheim Pharma GmbH & Co. KG |
| 07.30 pm – 10.00 pm | Scientific Networking session |
| FRIDAY, NOVEMBER 5, 2021 |
| 08.00 am – 09.30 am | Sponsored Breakfast Symposium (Non-CME) supported by Incyte Corporation |
| 09.30 am – 09.45 am
|
COFFEE BREAK
Chairs – Morning Session: |
| 09.45 am – 10.15 am | How to perform successful clinical trials in inflammatory skin diseases Kristian Reich (Hamburg, Germany) |
| 10.15 am – 10.45 am | PSORT – New psoriasis frontiers Christopher Griffiths (Manchester, UK) |
| 10.45 am – 11.15 am | Hidradenitis and pustular psoriasis James G. Krueger (New York, NY USA) |
| 11.15 am – 11.45 am | Psoriasis – the translational path and access to drugs Mark Lebwohl (New York, NY, USA) |
| 11.45 am – 12.00 pm | COFFEE BREAK |
| 12.00 pm – 01.30 pm | Sponsored Lunch Symposium (Non-CME) supported by Janssen Immunology, Pharmaceutical Companies of Johnson & Johnson |
| 01.30 pm – 01.45 pm
|
COFFEE BREAK
Chairs – Afternoon Session I: |
| 01.45 pm – 02.15 pm | Atopic dermatitis Emma Guttman (New York, NY, USA) |
| 02.15 pm – 02.45 pm | Dermatomyositis Victoria P. Werth (Philadelphia, PA, USA) |
| 02.45 pm – 03.15 pm | Regulation of human T-Cell responses by ionic signals in the skin Christina Zielinski (Munich, Germany) |
| 03.15 pm – 03.45 pm | Oral presentations from selected abstracts (non-CME)
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Vitiligo: 24-Week Results From 2 Randomized, Double-Blind Phase 3 Studies Sphingosine 1-phosphate receptor signalling promotes hair growth and inhibits perifollicular T-cell expansion and immune privilege collapse ex vivo Netherton syndrome subtypes share IL-17/IL-36 signature with distinct type I IFN, Th2 and Th9 responses |
| 03.45 pm – 04.15 pm
|
COFFEE BREAK
Chairs – Afternoon Session II: |
| 04.15 pm – 04.45 pm | Translating Itch Neuroimmunology to New Therapies Brian Kim (St Louis, MO, USA) |
| 04.45 pm – 05.15 pm | Immune and neural network interactions Dan Kaplan (Pittsburgh, PA, USA) |
| 05.15 pm – 05.45 pm | The skin microbiome in wound healing and regeneration Elizabeth Grice (Philadelphia, PA, USA) |
| 05.45 pm – 06.15 pm | Microbiome and immune interactions early in life Tiffany Scharschmidt (San Francisco, CA, USA) |
| 06.15 pm – 06.45 pm | White adipose tissue and its role in innate host defense Richard Gallo (San Diego, CA, USA) |
| 06.45 pm – 07.00 pm | COFFEE BREAK |
| 07.00 pm – 08.30 pm | Sponsored Dinner Symposium (Non-CME) supported by Sanofi Genzyme and Regeneron |
| SATURDAY, NOVEMBER 6, 2021 |
| 08.00 am – 09.30 am | Sponsored Breakfast Symposium (Non-CME) supported by Eli Lilly and Company |
| 09.30 am – 09:45 am
|
COFFEE BREAK
Chairs – Morning Session: |
| 09.45 am – 10.15 am | Artificial Intelligence in dermatology Harald Kittler (Vienna, Austria) |
| 10.15 am – 10.45 am | Alopecia areata Angela Christiano (New York, NY, USA) |
| 10.45 am – 11.15 am | Acne: a disorder of lipid metabolism Robert Modlin (Los Angeles, CA, USA) |
| 11.15 am – 11.45 am | Vitiligo John Harris (Worcester, MA, USA) |
| 11.45 pm – 12.15 pm | Inflammation and cancer Thomas S. Kupper (Boston, MA, USA) |
| 12.15 pm – 12.30 pm | COFFEE BREAK |
| 12.30 pm – 02.00 pm | Sponsored Lunch Symposium (Non-CME) supported by LEO Pharma |
| 02.00 pm – 03.00 pm | Chairs – Afternoon Session: Saakshi Khattri (New York, NY, USA) Maryanne Makredes Senna (Boston, MA, USA) Oral presentations from selected abstracts (non-CME) EASI p-EASI: predicting disease severity in atopic dermatitis patients treated with tralokinumab Histopathological Analysis of ECZTRA 1 Study Revealed the Reduction of Innate Lymphoid Cells in Skin of Atopic Dermatitis Patients After Tralokinumab Treatment Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis Correcting immunological misfiring in obesity restores efficacy of targeted biologic therapy for inflammatory skin disease |
| 03.00 pm – 03.30 pm | Lupus Virginia Pascual (New York, NY, USA) |
| 03.30 pm – 04.00 pm | Sarcoidosis & Granulomatous diseases Misha Rosenbach (Philadelphia, PA, USA) |
| 04.00 pm – 04.30 pm | Oral presentations from selected abstracts (non-CME)
Modulation of serum biomarkers from PsO patients treated with risankizumab or ustekinumab in a Phase 3 study Sensory ganglia reprogram in response to cutaneous inflammation |
| 04.30 pm – 06.00 pm | Sponsored Dinner Symposium (Non-CME) supported by AbbVie |
| 06.00 pm | Closing & Farewell |
Be sure to book your travel arrangements early. We are unable to reserve hotel rooms or airfare for attendees of the symposium. We suggest online travel services such as hotels.com, travelocity.com or orbitz.com. If you would like assistance with hotel arrangements, please contact our Housing Manager, Denise Newman by email: dnew229@aol.com or call 718-835-4911.
Online registration is open now.
REGISTER HERE
Please note that proof of vaccination will be necessary to attend the meeting in person at the New York Academy of Medicine.
| Regular Admission | USD 450 |
| Students*/ Residents**/ Fellows** | USD 200 |
*Student Fee: Students need to provide a copy of their valid Student ID when registering, otherwise the student registration will not be accepted.
** Resident: In order to verify your status as a resident, a written confirmation from your hospital/ institution will be required, otherwise regular admission will apply.
In-Person Attendance Policy
All in-person meeting participants must be fully vaccinated and must wear masks at all times. By registering for and attending the meeting, each participant affirms that they will comply with all CDC, federal, state, and local laws, orders, directives, and institutional guidelines related to COVID-19 and attending a large gathering.
We take the health and safety of our conference participants and staff seriously. We will continue to monitor the U.S. Centers for Disease Control and Prevention (CDC) and U.S. state and local health authorities for the latest public health updates, as well as applicable restrictions on events and gatherings. We plan to hold this meeting in hybrid format but reserve the right to convert it to a 100% virtual event if health and safety restrictions require it. We will update the registrants and the website should the plans for this event change.
Abstracts that have been submitted within the regular abstract submission deadline are published on the Wiley Online Library:
Experimental DermatologyVolume 30 Supplement 2 November 2021
Late-breaking abstracts can be downloaded here.
If you have any questions, please get in contact with
Sandra Wagner
Mondial Congress & Events
Mondial GmbH & Co. KG
Operngasse 20b, 1040 Vienna, Austria
t +43 1 58804-244, f -185
wagner@mondial-congress.com
The Academy is located at the corner of Fifth Avenue and 103rd Street.
The entrance is on 103rd Street.
BY SUBWAY
Take the 6 train to 103rd Street. Walk west on 103rd Street; after crossing Park Avenue, turn right and walk a few yards, and then turn left onto the path through the garden of Carver Houses to Madison Avenue. Continue west on 103rd Street almost to Fifth Avenue. The entrance to the Academy is on 103rd Street. Check the MTA website for updates on planned service changes.
FROM 42ND STREET/TIMES SQUARE:
Take Shuttle Train to 42nd / Street Grand Central and transfer to the #6 Train (Uptown) to 103rd Street.
BY BUS, FROM SOUTH OF 103RD STREET:
On Madison Avenue, take a northbound M1, M2, M3, or M4 bus to 103rd Street. Walk west on 103rd Street almost to Fifth Avenue. The entrance to the Academy is on 103rd Street.
BY BUS, FROM NORTH OF 103RD STREET:
On Fifth Avenue, take a southbound M1, M2, M3, or M4 bus to 103rd Street. The entrance to the Academy is on 103rd Street, on the southeast corner of the intersection of 103rd Street and Fifth Avenue.
FROM GRAND CENTRAL STATION/GRAND CENTRAL TERMINAL:
Exit Grand Central Station and Terminal on 42nd Street at Vanderbilt Avenue. Walk one short block west to Madison Avenue and take the M1, M2, M3 or M4 (Northbound) bus 103rd Street. Walk west on 103rd Street almost to Fifth Avenue. The entrance to the Academy is on 103rd Street.
FROM METRO NORTH/125TH STREET AND PARK AVENUE:
Exit the station and take the M101 bus on Lexington Avenue southbound to East 102nd Street. Walk three blocks east to Fifth Avenue and proceed north to 103rd Street.
FROM PORT AUTHORITY BUS TERMINAL:
Exit
the terminal at the West 42nd Street exit. Proceed to Eighth Avenue and
take the M42 Bus east to Madison Avenue. Transfer to the M1, M2, M3 or
M4 (Northbound) bus 103rd Street. Walk west on 103rd Street almost to
Fifth Avenue. The entrance to the Academy is on 103rd Street.
FROM PENNSYLVANIA STATION:
Exit
the terminal at the West 33rd Street exit. Proceed to Eighth Avenue and
take the M42 Bus east to Madison Avenue. Transfer to the M1, M2, M3 or
M4 (Northbound) bus 103rd Street. Walk west on 103rd Street almost to
Fifth Avenue. The entrance to the Academy is on 103rd Street.
BY CAR, FROM SOUTH OF 96TH STREET:
From
the FDR Drive North, take the 96th Street exit. Turn left onto 96th
Street, and drive straight until Madison Avenue. Turn right on Madison,
and drive north to 103rd Street.
Turn left, and the Academy is at the end of the block on the south side of the street.
BY CAR, FROM NORTH OF 96TH STREET:
From
the FDR Drive South, take the 96th Street exit. Turn right onto E. 96th
Street, and drive straight until Madison Avenue. Turn right on Madison,
and drive north to 103rd Street. Turn left, and the Academy is at the
end of the block on the south side of the street.
PARKING
There are several public parking lots in the area, including the following:
Manhattan Parking 10 East 102nd St. (Between Fifth and Madison Aves)
Standard Parking 14 East 103rd St. (Between Fifth and Madison Aves)
Merit Parking 12 East 107th St. (Between Fifth and Madison Aves)